OrsoBio has announced the publication in Nature Medicine of Phase I clinical trial data for TLC-2716, an oral liver-targeted ...

Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...

Point Total Score Reduction in Montgomery-Åsberg Depression Rating Scale (MADRS) on Day 7 (p=0.0094) ---- Demonstrated Rapid and Durable Efficacy Starting as Early as Day 1 and Continuing Through Day ...

According to Adalyon’s CEO, Ulrik Zeuthen, speech-based biomarkers can be used across several applications to optimise trial ...

Explore the unique mechanisms of bispecific antibodies and their rapid availability compared to CAR T-cell therapies in cancer treatment.

New research opens the door for more streamlined and patient-centric protocols, informed by benchmarking analysis of phase II and III protocol procedures PHILADELPHIA, Jan. 6, 2026 /PRNewswire/ -- ...

Interim results indicate NS002 demonstrated significantly faster absorption and higher peak epinephrine levels compared to ...

SHANGHAI, May 23, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at ...

As clinical research evolves at an unprecedented pace, it’s important that physicians understand how emerging trends may ...

A study using agentic artificial intelligence to detect early signs of cognitive decline in unstructured m | Mass General ...

New eTMF module integrates with Enlighten Clinical Solutions’ platform to support inspection-ready clinical trial ...

Patients’ financial resources affect their enrollment in oncology clinical trials to a greater degree than traditional ...